Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TOBRAMYCIN 60MG SOLUTION Resolved 2021-10-14 2021-12-17 147231
TEVA-SALBUTAMOL STERINEBS P.F. 2MG SOLUTION Resolved 2021-10-21 2022-10-18 147717
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2021-11-11 2021-12-11 149108
ACT PROGESTERONE INJECTION 50MG SOLUTION Actual shortage 2021-11-18 2022-08-18 149602
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-01-20 2022-04-21 153156
TEVA-IPRATROPIUM STERINEBS 250MCG SOLUTION Resolved 2022-01-20 2022-04-21 153165
TEVA-SALBUTAMOL STERINEBS P.F. 1MG SOLUTION Resolved 2022-01-20 2022-02-17 153186
TEVA-IPRATROPIUM STERINEBS 250MCG SOLUTION Resolved 2022-02-10 2022-07-01 154720
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-02-17 2022-03-24 155155
TEVA-IPRATROPIUM STERINEBS 250MCG SOLUTION Resolved 2022-04-28 2022-07-01 159590
TEVA-SALBUTAMOL STERINEBS P.F. 1MG SOLUTION Resolved 2022-06-16 2022-10-29 162858
TEVA-TOBRAMYCIN 60MG SOLUTION Resolved 2022-07-25 2022-12-08 165447
PEDIATRIX 160MG SOLUTION Resolved 2022-08-18 2023-06-27 167194
TEVA-TERIPARATIDE INJECTION 250MCG SOLUTION Resolved 2022-10-28 2022-12-15 173004
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-11-14 2023-01-12 174595
TEVA-COMBO STERINEBS 0.5MG 2.5MG SOLUTION Resolved 2022-12-01 2022-12-08 176827
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-01-12 2023-10-06 180891
TEVA-LACTULOSE 667MG SOLUTION Resolved 2023-02-02 2023-04-28 183401
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Resolved 2023-02-10 2023-03-23 184317
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-02-17 2023-04-28 185077

Showing 781 to 800 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250